← Back to Clinical Trials
RecruitingPhase 4NCT06278987
Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
ConditionHip Fractures
SponsorUniversity of Minnesota
Study TypeINTERVENTIONAL
PhasePhase 4
Enrollment150
SexALL
Min Age18 Years
Max Age85 Years
Start Date2024-10-01
Completion2026-10-01
Interventions
PENG block and cryoablationfascia iliaca compartment block
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing hip fracture repair aged 18-85. Exclusion Criteria: * Patients who have an exclusion to regional anesthesia. * Patients who are pregnant assessed via self-report or pregnancy test if they have taken one. * Non-English speakers * Patients who already had their fracture repaired"
Related Trials
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology